Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient Therapy
Open Access
- 23 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e78152
Abstract
Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years with a still continuing shift from inpatient to outpatient treatment. This development is mainly caused by outpatient availability of highly efficient and relatively well-tolerated systemic treatments, in particular BioLogicals. In addition, inpatient treatment is time- and cost-intense, conflicting with the actual burst of health expenses and with patient preferences. Nevertheless, inpatient treatment with dithranol and UV light still is a major mainstay of psoriasis treatment in Germany. The current study aims at comparing the total costs of inpatient treatment and outpatient follow-up to mere outpatient therapy with different modalities (topical treatment, phototherapy, classic systemic therapy or BioLogicals) over a period of 12 months. To this end, a retrospective cost-of-illness study was conducted on 120 patients treated at the University Medical Centre Mannheim between 2005 and 2006. Inpatient therapy caused significantly higher direct medical, indirect and total annual costs than outpatient treatment (13,042 € versus 2,984 €). Its strong influence on cost levels was confirmed by regression analysis, with total costs rising by 104.3% in case of inpatient treatment. Patients receiving BioLogicals produced the overall highest costs, whereas outpatient treatment with classic systemic antipsoriatic medications was less cost-intense than other alternatives.Keywords
This publication has 34 references indexed in Scilit:
- Patient preferences for psoriasis treatments: impact of treatment experienceJournal of the European Academy of Dermatology and Venereology, 2012
- Gesundheitsökonomische Aspekte der PsoriasistherapieDie Dermatologie, 2005
- Costs of Treatment in Patients With Moderate to Severe Plaque PsoriasisArchives of Dermatology, 2004
- Inpatient hospital care for psoriasis: a vanishing practice in the United StatesJournal of the American Academy of Dermatology, 2003
- Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and costExpert Opinion on Pharmacotherapy, 2003
- Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatmentBritish Journal of Dermatology, 2002
- The direct cost of care for psoriasis and psoriatic arthritis in the United StatesJournal of the American Academy of Dermatology, 2002
- The cost of psoriasis treatment.2001
- Duration of remission of psoriasis therapiesJournal of the American Academy of Dermatology, 1999
- The Effectiveness of Modified Ingram Therapy Compared with Severity of PsoriasisThe Journal of Dermatology, 1998